Thanks for gurgling out those positives, Rob.
Immunotherapy is alive and still going strong.
Merck has not given up on stimuvax inspite of having to terminate their phase 3 trial on testing with non small cell lung cancer. What they found out was that some sub groups in the trial did better than others. Armed with data from the failure, Merck has continued to trial stimuvax on other types of cancer. Likewise, Prima is going to test cvac on other types of cancer. I hope that tough to treat, pancreatic cancer is first off the block.
- Forums
- ASX - By Stock
- all good with prr
Thanks for gurgling out those positives, Rob.Immunotherapy is...
-
- There are more pages in this discussion • 19 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add IMM (ASX) to my watchlist
|
|||||
Last
29.0¢ |
Change
-0.005(1.69%) |
Mkt cap ! $428.5M |
Open | High | Low | Value | Volume |
30.0¢ | 30.5¢ | 28.5¢ | $554.7K | 1.885M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
18 | 287567 | 29.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
29.5¢ | 172589 | 30 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
17 | 293037 | 0.290 |
29 | 611589 | 0.285 |
17 | 264479 | 0.280 |
9 | 184629 | 0.275 |
18 | 352894 | 0.270 |
Price($) | Vol. | No. |
---|---|---|
0.295 | 181989 | 31 |
0.300 | 284818 | 18 |
0.305 | 240673 | 14 |
0.310 | 266401 | 9 |
0.315 | 147005 | 7 |
Last trade - 15.19pm 08/07/2024 (20 minute delay) ? |
Featured News
IMM (ASX) Chart |